Texas ChE Professor Tom Edgar’s leadership in clean energy research recently helped secure $140 million for a new Smart Manufacturing Innovation Institute that will improve the efficiency of advanced manufacturing systems and deliver dramatic energy savings nationwide.
Texas ChE graduate student Shuqi Zhang has worked with a team of researchers led by biomedical engineering Assistant Professor Jenny Jiang to develop a novel technique that can measure the effectiveness of T-cells, a type of immune cell programmed to fight or kill a threat. The technique could benefit immunotherapy and vaccine development, resulting in … Read the rest »
A team of researchers in the Cockrell School of Engineering at The University of Texas at Austin, including McKetta Department of Chemical Engineering professor Jennifer Maynard, have been awarded a $100,000 grant from the Grand Challenges Explorations initiative, a program funded by the Bill & Melinda Gates Foundation, to pursue research aimed at improving … Read the rest »
Texas ChE offered a new course this semester, ChE 379 Entrepreneurship, led by alumnus and established entrepreneur Michael Piana.
The elective introduces upperclassmen and graduate students to the basic concepts of entrepreneurship and the practical approaches of taking a business idea and monetizing it. Students of the course explore the keys to understanding the business … Read the rest »
Previously published on the Undergraduate Research Journal for The University of Texas at Austin as “UT Alumni: An Interview with Caitlin Spofford” by Venkat Tirumala, Assistant Editor of Natural Sciences.
Caitlin Spofford graduated from The University of Texas at Austin with a bachelors degree from the McKetta Department of Chemical Engineering on December … Read the rest »
Researchers at The University of Texas at Austin, including Texas ChE’s Dr. George Georgiou and Dr. Jennifer Maynard, successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA). Part … Read the rest »
Today the U.S. Food and Drug Administration approved the drug product Zepatier for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Texas ChE Ph.D. student Angela Wagner of Professor Nicholas Peppas’ research group was one of the team of eight researchers to co-invent and patent Zepatier.
Hepatitis … Read the rest »
Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »
Inspired by a naturally occurring material found in marine mussels, researchers in the McKetta Department of Chemical Engineering have created a new flame retardant to replace commercial additives that are often toxic and can accumulate over time in the environment and living animals, including humans.
Flame retardants are added to foams found in mattresses, sofas, … Read the rest »
The Cockrell School of Engineering at The University of Texas at Austin is launching the university’s first health care engineering institute dedicated to developing technologies and treatments that will immediately improve patient quality of life.